Market Place
Sourcing Support
CDMO Activity Tracker: CDMOs expand operations in cell and gene therapies, biologics, HPAPIs
The Covid-19 pandemic expedited the
growth of contract development and manufacturing organizations
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Mylan’s President, Emcure’s CEO named in US drug price-fixing probe; Novartis buys French biotech for US$ 3.9 billion
This week in Phispers, we look at how Mylan’s president Rajiv Malik and Emcure’s CEO Sat
Lundbeck’s CEO to head Teva; Pfizer gets FDA warning letter for supplying faulty EpiPens
This
week, Phispers brings you news about Teva, which finally found a CEO in Kare
Schultz. Allerga
US introduces bills to let FDA recall unsafe drugs, allow drug imports from Canada
In Phispers this week, we bring you news on two new bills in the US that seek to bring in cheaper me
FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More
After 2 years of sky-high approval numbers, the US Food and Drug Administration’s (FDA) Center
Sanofi’s rough week; Quality snags at Pfizer; FDA warns against commonly used drug
This week, Phispers delves into Pfizer’s acquisition of Medivation and its impact on Sanofi. T
GSK, Google form first bioelectronics firm; 11 generic companies benefit from the Teva Allergan deal
This week,
Phispers brings to you the details of the bioelectronics firm formed by GSK and
Google. T
Haunted: Teva’s $1.2 billion ‘pay-for-delay’ penalty; which companies will get hit next?
Teva Pharmaceutical Industries, Ltd., which acquired Cephalon in 2012, will make a total payment of
